BRIEF-Myriad's EndoPredict study meets primary endpoint By: Reuters: Company News July 11, 2016 at 11:34 AM EDT * Myriad announces positive results for an EndoPredict clinical study published in Journal of National Cancer Institute Read More >> Related Stocks: Myriad Genetics Inc